Anti-Mullerian Hormone as A new Marker for Diagnosis of Poly Cystic Ovary Syndrome

October 2019 in “ The Egyptian Journal of Hospital Medicine ”

Abdel Monieum Mohamed Zakaria, Ahmed Osama, Ahmed Kamal Mohamed Abo Sheashea

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on ejhm.journals.ekb.eg →

Discuss this study in the Community →

Related Research

3 / 3 results

research Reconsidering PCOS Etiology, Diagnosis, Clinical Subgroups, and Subgroup-Specific Treatments

January 2024 in “Endocrine and metabolic science”

Different types of PCOS need specific diagnosis methods and treatments.

research Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment

5 citations , October 2021 in “Meditsinskiy sovet = Medical Council”

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

research Screening for Diabetes in Women with Polycystic Ovary Syndrome

3 citations , March 2007 in “Canadian Medical Association Journal”

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.